Literature DB >> 11752503

Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle.

C Turesson1, P Englund, L T Jacobsson, G Sturfelt, L Truedsson, I Nennesmo, I E Lundberg.   

Abstract

OBJECTIVE: To investigate markers of endothelial activation in muscle biopsies from rheumatoid arthritis (RA) patients with and without extra-articular manifestations (ExRA). PATIENTS AND METHODS: Nine consecutive ExRA patients were compared with nine RA controls without ExRA, matched for age, sex and duration of RA. Muscle biopsies were obtained from the lateral vastus or anterior tibial muscle. Macrophage and lymphocyte CD markers, HLA molecules, cytokines and adhesion molecules were investigated using immunohistochemistry, and stainings were evaluated using computer image analysis and conventional microscopy. Serum concentrations of soluble adhesion molecules, tumour necrosis factor alpha (TNF-alpha) and rheumatoid factor (RF) were determined using immunoassays.
RESULTS: The number of HLA-DQ-positive capillaries (P=0.039) and the expression of interleukin 1alpha (IL-1alpha) in endothelial cells (mean pairwise difference 0.26%; 95% confidence interval 0-0.52) were increased in ExRA patients compared with non-ExRA controls. There were no signs of inflammatory cell infiltrates or fibre degeneration. Serum levels of TNF-alpha, the soluble form of intercellular adhesion molecule 1, the soluble form of vascular cell adhesion molecule 1 and IgM RF were increased in the ExRA group.
CONCLUSION: The increased expression of HLA-DQ and IL-1alpha may indicate systemic endothelial activation in extra-articular RA, which could be of importance for cardiovascular comorbidity and mortality in such patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752503     DOI: 10.1093/rheumatology/40.12.1346

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

1.  [Extra-articular manifestations of rheumatoid arthritis].

Authors:  C Baerwald; C Kneitz; M Bach; M Licht
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

2.  Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis.

Authors:  C Turesson; L T H Jacobsson; G Sturfelt; E L Matteson; L Mathsson; J Rönnelid
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

Review 3.  Unresolved issues in biologic therapy for rheumatoid arthritis.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

Review 4.  The skeletal muscle arachidonic acid cascade in health and inflammatory disease.

Authors:  Marina Korotkova; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

5.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

6.  Constitutive repression of interleukin-1alpha in endothelial cells.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2008-02-21       Impact factor: 17.367

7.  Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study.

Authors:  C Turesson; A Jarenros; L Jacobsson
Journal:  Ann Rheum Dis       Date:  2004-03-29       Impact factor: 19.103

8.  Differential regulation of endothelial cell activation by complement and interleukin 1alpha.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2006-03-02       Impact factor: 17.367

Review 9.  Indications for biotherapy in systemic vasculitides.

Authors:  Loïc Guillevin; Christian Pagnoux; Philippe Guilpain; Boris Bienvenu; Valérie Martinez; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

10.  Circulating E-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis.

Authors:  Esther G Corona-Sanchez; Laura Gonzalez-Lopez; Jose F Muñoz-Valle; Monica Vazquez-Del Mercado; Maria A Lopez-Olivo; Erika A Aguilar-Chavez; Mario Salazar-Paramo; Carlos Loaiza-Cardenas; Edith Oregon-Romero; Rosa E Navarro-Hernandez; Jorge I Gamez-Nava
Journal:  Rheumatol Int       Date:  2008-08-23       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.